Literature DB >> 16923955

Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity.

Simon Mead1, Mark Poulter, Jon Beck, Thomas E F Webb, Tracy A Campbell, Jacqueline M Linehan, Melanie Desbruslais, Susan Joiner, Jonathan D F Wadsworth, Andrew King, Peter Lantos, John Collinge.   

Abstract

By far the largest known kindred with an inherited prion disease caused by a prion protein (PrP) octapeptide repeat insertion mutation originates from southeast England. This extended family shows very marked phenotypic heterogeneity and provides a unique opportunity to characterize this diversity and examine possible modifying factors amongst a large number of individuals in whom prion disease has been initiated by the same defined genetic mutation. As the inherited prion diseases comprise a significant proportion of familial early-onset dementia, an appreciation of their wide range of clinical presentation is important for differential diagnosis. Genealogical and clinical record review, together with the characterization of the mutation-linked single nucleotide polymorphism and microsatellite haplotype, suggested a single founder for both this large kindred and a smaller family in the mid-18th century. Here we report the phenotype of 86 affected individuals; at least another 84 individuals are known to be at risk of inheriting the disease. Clinical onset, typically with cognitive impairment, can be strikingly early in this kindred when compared with other inherited or sporadic prion diseases. We have investigated the effect of PrP genotype, candidate genes and prion strain type on clinical, neuroradiological and neuropathological phenotype. The transmission characteristics of prions from affected individuals resembled those of classical sporadic Creutzfeldt-Jakob disease. One surprising finding was a strong inverse correlation between age of onset and disease duration. The PrP gene polymorphic codon 129 was found to confer 41% of the variance in age of onset but interestingly this polymorphism had no effect on disease duration suggesting different molecular mechanisms are involved in determining disease onset and rate of clinical progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923955     DOI: 10.1093/brain/awl226

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  41 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Clinical findings and diagnosis in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Uta Heinemann; Claudia Ponto; Jasmine Kortt; Kai Kallenberg; Daniela Varges; Walter J Schulz-Schaeffer; Hans A Kretzschmar; Inga Zerr
Journal:  Eur J Epidemiol       Date:  2015-06-16       Impact factor: 8.082

3.  How does the genetic assassin select its neuronal target?

Authors:  James C Stevens; Elizabeth M C Fisher; Simon Mead
Journal:  Mamm Genome       Date:  2011-03-04       Impact factor: 2.957

Review 4.  The diagnosis of young-onset dementia.

Authors:  Martin N Rossor; Nick C Fox; Catherine J Mummery; Jonathan M Schott; Jason D Warren
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

5.  The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.

Authors:  Tiziana Sonati; Regina R Reimann; Jeppe Falsig; Pravas Kumar Baral; Tracy O'Connor; Simone Hornemann; Sine Yaganoglu; Bei Li; Uli S Herrmann; Barbara Wieland; Mridula Swayampakula; Muhammad Hafizur Rahman; Dipankar Das; Nat Kav; Roland Riek; Pawel P Liberski; Michael N G James; Adriano Aguzzi
Journal:  Nature       Date:  2013-07-31       Impact factor: 49.962

Review 6.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

7.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

8.  Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

9.  Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.

Authors:  Jamie C Fong; Julio C Rojas; Jee Bang; Andrea Legati; Katherine P Rankin; Sven Forner; Zachary A Miller; Anna M Karydas; Giovanni Coppola; Carrie K Grouse; Jeffrey Ralph; Bruce L Miller; Michael D Geschwind
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

Authors:  A M Isaacs; C Powell; T E Webb; J M Linehan; J Collinge; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-08       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.